New regimens of benznidazole for the treatment of chronic Chagas disease in adult participants in indeterminate form or with mild cardiac progression (NuestroBen study): protocol for a phase III randomised, multicentre non-inferiority clinical trial

Tayná MarquesColin ForsythFabiana BarreiraCarola LombasB OliveiraMónica LasernaIsrael MolinaMaría del Carmen BangherRosa Martí FernándezSusana Lloveras2026-03-222026-03-22202510.1136/bmjopen-2024-098079https://doi.org/10.1136/bmjopen-2024-098079https://andeanlibrary.org/handle/123456789/77960NCT04897516.enMedicineBenznidazoleInternal medicineIndeterminateChagas diseaseDiseaseEpidemiologyOncologyQuality of Life ResearchClinical trialNew regimens of benznidazole for the treatment of chronic Chagas disease in adult participants in indeterminate form or with mild cardiac progression (NuestroBen study): protocol for a phase III randomised, multicentre non-inferiority clinical trialarticle